Humana Inc. (NYSE: HUM) today released details of its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2023 – with a clear focus on benefits and support based on what its members have said they want and need. The news comes after the company’s pledge earlier this year to identify $1 billion in cost savings to invest back into its Medicare Advantage program and CenterWell
→ Google Traduction
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), is donating $1 million towards relief and recovery efforts for those impacted by Hurricane Ian in Florida and Hurricane Fiona in Puerto Rico. Humana has also taken steps to aid communities in each storm’s path, including opening access to a crisis hotline with free counseling available. This press release features multimedia.
→ Google Traduction
Humana Inc. found using ticker (HUM) have now 22 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 590 and 514 calculating the mean target price we have 549.73. Now with the previous closing price of 487.31 this now indicates there is a potential upside of 12.8%. There is a 50 day moving average of 487.65 and the 200 moving average now moves to 450.62. The market cap for the company is $62,494m. You can visit the company''s website by visiting: https://www.humana.com [stock_market_widget type="chart" template="basic" color="green" assets="HUM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $70,498m based on the market concensus. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals.
→ Google Traduction
Cano Health (CANO) stock is moving on Friday from reports that Humana (HUM) and CVS (CVS) are considering buying the company.
→ Google Traduction
Yahoo Finance Live anchors discuss reports that Humana and CVS are interested in acquiring Cano Health.
→ Google Traduction
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO ) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero''s late-stage antibiotic asset, tebipenem HBr. Spero Therapeutics will receive $66 million upfront, with potential for future milestone payments, and tiered royalties. Avenue Therapeutics, Inc. (NASDAQ: ATXI ) gained 105.9% to close at $0.44 after the company received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol. The company also announced the effectiveness of its 1-for-15 reverse split on Sept. 23. Panbela Therapeutics, Inc. (NASDAQ: PBLA ) gained 46.4% to close at $0.3550. American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT ) jumped 44.7% to close at $0.3118 on Thursday. ShiftPixy, Inc. (NASDAQ: PIXY ) shares gained 39% to close at $18.98. ShiftPixy, on Wednesday, announced pricing of $5 million private placement. Cassava Sciences, Inc. (NASDAQ: SAVA ) climbed 35.7% to close at $51.06.
→ Google Traduction
Equities in Toronto plumbed a fresh two-week low on Thursday, as technology and health-care stocks weighed matters down, as investors continued to fret over the pace of interest rate hikes by major central banks. The TSX Composite fell 181.86 points, or 1%, to close Thursday at 19,002.68. The Canadian dollar skidded 0.44 cents to 74.14 cents U.S. Losses in information technology did most of the damage, with Dye & Durham, down 82 cents, or 6.4%, to $12.08, while Nuvei ditched $2.65, or 6.5%, to $37.87. Real-estate also faltered, with units of Summit Industrial Income REIT falling back 66 cents, or 3.7%, to $17.05, while Colliers International sank $5.20, or 3.6%, to $138.27. Health-care did not fare much better, as Canopy Growth went down the scale 26 cents, or 6.6%, to $3.69, while Tilray dipped 21 cents, or 5.3%, to $3.79. Communications, one of the two subgroups which tried to shine, was powered by Telus, improving 42 cents, or 1.5%, to $28.90, while Rogers surged 70 cents, or 1.3%, to $55.80.
→ Google Traduction
Stocks fell for a second session on Thursday following the Federal Reserve’s aggressive rate hike, as investors increasingly fear the central bank will push the economy into a recession as it battles to curb rising inflation. The Dow Jones Industrials lost 107.1 points to end Thursday’s session at 30,076.68. The 30-stock index flirted with gains through the day but stayed in negative territory for most of the session. The S&P 500 retreated 31.94 points to 3,760.23. The NASDAQ Composite slid 153.39 points, or 1.4%, to 11,066.81. Defensive stocks outperformed with drugmakers and consumer staples in the green on Thursday. Eli Lilly shares gained 4% after UBS upgraded the stock and said it could be developing the biggest drug ever. Shares of Cano Health surged more than 40% in late afternoon trading following a Wall Street Journal report that Humana and other potential buyers are in talks to buy the primary-care provider. All the major averages are on pace to finish the week with losses. The Dow is down about 2.1%, while the S&P is negative 2.6%, and NASDAQ has tumbled 3.1%.
→ Google Traduction
Humana and CVS Health are among the several companies looking to buy senior-care facility operator Cano Health, according to media reports on Thursday, sending Cano’s shares up about 50%. The talks are serious and a deal to purchase Cano could be struck in the next several weeks, the Wall Street Journal said on Thursday citing […]
→ Google Traduction
New Jersey, USA -- ( SBWIRE ) -- 09/21/2022 -- The latest study released on the Global Individual Health Insurance Market by AMA Research evaluates market size, trend, and forecast to 2027. The Individual Health Insurance market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Download Sample Report PDF (Including Full TOC, Table & Figures) @ https://www.advancemarketanalytics.com/sample-report/3008-global-individual-health-insurance-market-1#utm_source=SBWireShraddha Key Players in This Report Include: HDFC Ergo (India), Niva Bupa (India), Kotak General Insurance (India), IFFCO-Tokio (India), Bharti AXA Life (India), Zurich Insurance Group (Switzerland), Munich Re (Germany), Aetna Inc. (United States), Anthem (United States), Cigna (United States), Blue Shield of California (United States), Humana Inc. (United States), Kaiser Permanente (United States), PingAn Insurance (China), Aon plc (United Kingdom) Definition: The individual health insurance plan offers benefits to the individuals its doesn''t cover family members.
→ Google Traduction
Retirement insurance Market Analysis & Forecast for Next 5 Years New Jersey, NJ -- ( SBWIRE ) -- 09/20/2022 -- Global Retirement insurance Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2027 is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Retirement insurance Market. Some of the key players profiled in the study are UnitedHealth Group (United States), Zurich Insurance (Switzerland), Humana (United States), Cigna (United States), Kaiser Permanente (United States), Mutual of Omaha (United States), Anthem (United States), Aetna (United States), AIA Group (Hong Kong), Alignment Healthcare (United States). Get free access to sample report @ https://www.htfmarketreport.com/sample-report/4140358-global-retirement-insurance-market Retirement insurance Market Overview: Retiree insurance is a form of health coverage an employer may provide to former employees.
→ Google Traduction
Shares of Humana Inc. (NYSE:HUM) traded at a new 52-week high today of $514.98. Approximately 763,000 shares have changed hands today, as compared to an average 30-day volume of 706,000 shares. Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built […]
→ Google Traduction
Shares of health insurance and well-being company Humana (NYSE:HUM) have remained resilient to the sharp selloff in the equities this year. It is trading in the green, compared to the 19% decline in the S&P 500 (SPX) Index. Other than its ability to defend its market share, the company''s durable earnings and strong visibility over future growth keep Wall Street analysts bullish on HUM stock. Humana Projects Strong Earnings Growth During the recently held virtual Investor Day, Humana raised its Fiscal 2022 earnings outlook. It expects to deliver adjusted earnings of approximately $25, up from the previous guidance of $24.75. Furthermore, the new earnings forecast reflects solid 21% year-over-over growth.
→ Google Traduction
At the close of the New York Stock Exchange, the Dow Jones fell 0.56% to a one-month low, the S&P 500 fell 1.13% and the NASDAQ Composite fell 1.43%. UnitedHealth Group Incorporated was the top performer in the Dow Jones Index today, up 13.14 points or 2.58% to close at 522.91. JPMorgan Chase & Co rose 1.75 points or 1.51% to close at 117.87. Goldman Sachs Group Inc rose 4.36 points or 1.33% to close at 331.62. The losers were Salesforce Inc, which shed 5.50 points or 3.43% to end the session at 154.78. Microsoft Corporation was up 2.71% or 6.84 points to close at 245.38, while Visa Inc Class A was down 2.03% or 4.04 points to close at 195. .37. Leading gainers among the S&P 500 index components in today''s trading were Humana Inc, which rose 8.37% to 497.24, Wynn Resorts Limited, which gained 7.48% to close at 65.23, and shares of Paramount Global Class B, which rose 5.16% to close the session at 23.05. The losers were Adobe Systems Incorporated, which shed 16.79% to close at 309.13. Shares of Albemarle Corp shed 6.49% to end the session at 286.75.
→ Google Traduction
Humana''s updated EPS outlook comes thanks to the release of the Covid headwind it held in its guidance.
→ Google Traduction
The shares of Humana Inc. (HUM) gained ~9% Thursday, recording the best intraday gain since April 2020 after the company raised its full-year 2022 outlook and set its 2025 adj
→ Google Traduction
New Jersey, USA -- ( SBWIRE ) -- 09/15/2022 -- The Latest Released Supplemental Health Insurance Market study by AMA Research has evaluated the future growth potential of Supplemental Health Insurance market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential drivers, challenges, opportunities, and restraints in the Supplemental Health Insurance market. Download Sample Report PDF (Including Full TOC, Table & Figures) @ https://www.advancemarketanalytics.com/sample-report/155945-global-supplemental-health-insurance-market#utm_source=SBWire/Suraj Key Players in This Report Include: Aetna Inc. (United States), Anthem, Inc. (United States), Bankers Fidelity Life Insurance Company (United States), Bupa (United Kingdom), Chubb Limited (United States), Cigna (United States), DKV Luxembourg SA (Luxembourg), Everest Re Group, Ltd. (Bermuda), Humana Inc. (United States), ManhattanLife (United States), MetLife, Inc. (United States), Mutual of Omaha (United States), Nationwide Mutual Insurance Company (United States), State Farm (United States), Transamerica Corporation (United States), United American Insurance Company (United States), United HealthCare Service LLC (United States) Definition: Supplemental health insurance is additional insurance that can cover some out-of-pocket expenses such as copayments, coinsurance, and deductibles that primary health insurance plans don''t pay.
→ Google Traduction
Source: Keith Homan / Shutterstock.com Humana (NYSE: HUM ) stock is heading higher on Thursday after the health insurance company revised its guidance during its Investor Day event. That revised guidance now has Humana expecting adjusted earnings per share of approximately $25 for the full year of 2022. The prior outlook was for $24.75 per share. To put that in perspective, Wall Street is expecting the company to report an adjusted EPS of $24.83 for the year. To go along with that, Humana also introduced a new adjusted EPS guidance of $37 per share for the full year of 2025. This represents a compounded annual growth rate of 14% compared to its latest adjusted EPS guidance for 2022. Bruce Broussard, president and CEO of Humana, said the following about the earnings report. “We are confident in our ability to deliver compelling, sustainable earnings growth, both in the near and longer term which will continue to drive shareholder value. Our strong competitive positioning and unique capabilities in the highly attractive individual Medicare Advantage market, coupled with the opportunity to scale and further integrate our CenterWell healthcare services capabilities, positions us for durable leadership in the value-based care industry.” HUM is seeing decent trading today with some 700,000 shares on the move.
→ Google Traduction
Humana Inc. (NYSE:HUM) price on Friday, September 09, fall -1.62% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $478.50. A look at the stock’s price movement, the close in the last trading session was $486.36, moving within a range at $478.12 and $487.47. The beta value (5-Year … There Is A Lot Of Upside Potential For Humana Inc.(NYSE: HUM) Read More »
→ Google Traduction
Humana enjoys a stable revenue stream, derived mostly from government-sponsored healthcare benefit programs. See why HUM stock is undervalued.
→ Google Traduction
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a-” (Excellent) for the majority of the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE: HUM]. These subsidiaries collectively are referred to as Humana Health Group. Concurrently, AM Best has affirmed the Long-Term ICR of “bbb-” (Good) and the Long-Term Issue Credit Ratings
→ Google Traduction
According to a new report from Goldman Sachs (NYSE: GS ), hedge funds and mutual funds are starting to rotate back into growth stocks from value stocks. These investors are steadily building up their positions in industries like information technology and consumer discretionary. Sub-sectors within these industries include auto, semiconductors and e-commerce. In a client note, top U.S. equity strategist David Kostin added: Mutual funds moved 66 bp away from Value, but still rank in the 79th percentile vs. the past 10 years. Hedge funds added 74 bp of exposure to Growth and cut length in Value by 30 bp. However, hedge funds are still less tilted to Growth than usual (508 bp vs. 728 bp average). The report also shows that mutual funds’ exposure to growth stocks are their highest levels since mid-2018. In addition, many mutual funds are increasing their exposure to mega-cap tech names, such as Tesla (NASDAQ: TSLA ), and Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ). 5 Growth Stocks That Hedge Funds Are Buying Now Growth stocks have experienced a rough year thus far.
→ Google Traduction
P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) and Humana, a leading health and well-being company, have signed an agreement that gives Humana Medicare Advantage members access to P3’s primary care provider (“PCP”) network. Under the new
→ Google Traduction
Humana Inc. with ticker code (HUM) have now 23 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 585 and 450 with the average target price sitting at 534.13. Given that the stocks previous close was at 493.19 this now indicates there is a potential upside of 8.3%. The 50 day MA is 477.02 while the 200 day moving average is 444.74. The company has a market capitalisation of $62,725m. Company Website: https://www.humana.com [stock_market_widget type="chart" template="basic" color="green" assets="HUM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $67,932m based on the market concensus. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
→ Google Traduction
Humana has yet again hit a 52-week record, reaching $504.99 on Monday. The health insurer reached new 52-week highs on August 15 and August 19.
→ Google Traduction
Adds plans that already serve 15 million older Americans Medicare plans from UnitedHealthcare and Aetna are now available for older Americans on Hella Health, a state-of-the-art digital advisor that transforms the Medicare shopping experience. With UnitedHealthcare and Aetna plans on its platform alongside its existing Humana and multiple regional plan relationships, Hella can now offer […] The post UnitedHealthcare And Aetna Added To Hella Health’s Growing Digital Medicare Enrollment Platform appeared first on AiThority .
→ Google Traduction
This Is What Hedge Funds Bought And Sold In Q2: Full 13F Summary While we already covered what may have been the most boring 13F of the second quarter, namely that of Berkshire Hathaway which saw very few changes with Warren Buffett merely adding to a few legacy positions and trimming a few others (full breakdown here)… ... as well as the most interesting one, that from Tiger Global which confirmed that the so-called hedge fund was nothing more than a paper-hands retail investor, dumping most of its biggest holdings just as the market troughed, and leaving the world''s most overrated tech fund missing on all of the recent market upside... ... we also have had quite a few hedge funds inbetween. Courtesy of Bloomberg here are the highlights of the just concluded 13F seasons: Risk off: Chase Coleman’s Tiger Global Management, Dan Sundheim’s D1 Capital and Michael Burry’s Scion Asset Management were among firms that continued to offload equities in the period. Tiger’s aggregate exposure to stocks dropped by about 55% to $11.8 billion.
→ Google Traduction
The Louisville-based public company also completed its $2.8 billion transaction to divest its majority interest in Kindred at Home this week.
→ Google Traduction
Humana (HUM) has agreed to acquire substantially all of the assets of Wisconsin-based managed care organization, Inclusa.Terms of the deal were not disclosed
→ Google Traduction
Humana Inc. found using ticker (HUM) have now 24 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 583 and 450 calculating the average target price we see 532.71. Given that the stocks previous close was at 487.74 this would imply there is a potential upside of 9.2%. The 50 day MA is 467.06 and the 200 day MA is 442.98. The market capitalisation for the company is $61,505m. You can visit the company''s website by visiting: https://www.humana.com [stock_market_widget type="chart" template="basic" color="green" assets="HUM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $67,176m based on the market concensus. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals.
→ Google Traduction
The stock market typically grows bumpy in the late summer as the second-quarter earnings season winds down. The fact is I believe any dip in my fundamentally superior Accelerated Profits stocks is a good buying opportunity – and based on recent action, I’m not the only one. Our friends at Bespoke recently pointed out that the bull/bear spread has dropped below 20% for only the fifth time since 1990. When the bull/bear has dropped below 20% before, the S&P 500 went on to post median returns of 2.7% in the following month, 9.19% in the next three months, 14.73% in the following six months, and 20.37% a year out. This is a very bullish signal. So, while there may be some short-term volatility, stocks are headed higher long term. In the near term, earnings are working. In other words, companies are beating estimates and that’s propelling their stock higher; and companies that miss expectations are falling. A couple of weeks ago we highlighted this with Elon Musk’s Tesla, Inc . (NASDAQ: TSLA ) after the electric car maker posted better-than-expected earnings.
→ Google Traduction
Humana Inc. with ticker code (HUM) have now 24 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 583 and 450 with a mean TP of 532.71. Given that the stocks previous close was at 478.39 this indicates there is a potential upside of 11.4%. The day 50 moving average is 463.46 and the 200 day MA is 442.16. The market cap for the company is $60,974m. Find out more information at: https://www.humana.com [stock_market_widget type="chart" template="basic" color="green" assets="HUM" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $67,897m based on the market concensus. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
→ Google Traduction
https://www.investing.com/news/pro/humana-pt-raised-to-494-at-morgan-stanley-432SI-2859683
→ Google Traduction
New Jersey, USA -- ( SBWIRE ) -- 07/29/2022 -- Advance Market Analytics published a new research publication on "Online Medical Insurance Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Online Medical Insurance market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/129542-global-online-medical-insurance-market Some of the key players profiled in the study are: Allstate (United States), Progressive (United States), United Healthcare Group (United States), Anthem (United States), Aetna (United States), Cigna (United States), Humana (United States), Centene (United States), Molina healthcare (United States), Wellcare health plans (United States).
→ Google Traduction
CIGNA (CI) declares $1.12/share quarterly dividend, in line with previous.
→ Google Traduction